Katherine McArthur
Poseida Therapeutics (United States)(US)
Publications by Year
Research Areas
CAR-T cell therapy research, Ubiquitin and proteasome pathways, Angiogenesis and VEGF in Cancer, Multiple Myeloma Research and Treatments, Biosimilars and Bioanalytical Methods
Most-Cited Works
- → Lynamicins A−E, Chlorinated Bisindole Pyrrole Antibiotics from a Novel Marine Actinomycete(2008)147 cited
- → A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105(2018)113 cited
- → Enantioselective Total Synthesis of (−)-Salinosporamide A (NPI-0052)(2007)86 cited
- → Leaving Groups Prolong the Duration of 20S Proteasome Inhibition and Enhance the Potency of Salinosporamides(2008)53 cited
- → Effects of Halogens on the Production of Salinosporamides by the Obligate Marine Actinomycete Salinispora tropica(2007)34 cited
- → Snapshots of the Fluorosalinosporamide/20S Complex Offer Mechanistic Insights for Fine Tuning Proteasome Inhibition(2009)33 cited
- → Proteasome Regulator Marizomib (NPI-0052) Exhibits Prolonged Inhibition, Attenuated Efflux, and Greater Cytotoxicity than Its Reversible Analogs(2011)32 cited
- → Clinical Trials of BCMA-Targeted CAR-T Cells Utilizing a Novel Non-Viral Transposon System(2021)25 cited
- → Early Safety Results of P-BCMA-ALLO1, a Fully Allogeneic Chimeric Antigen Receptor T-Cell (CAR-T), in Patients with Relapsed / Refractory Multiple Myeloma (RRMM)(2023)23 cited
- → Unique butyric acid incorporation patterns for salinosporamides A and B reveal distinct biosynthetic origins(2007)15 cited